Skip to main content

Advertisement

Table 3 Anxiety and depression as a function of eczema, with cumulative adjustments for possible contributing factors.

From: Factors accounting for the association between anxiety and depression, and eczema: the Hordaland health study (HUSK)

  Anxiety Depression Both
Cumulative adjustments OR 95%CI OR 95%CI OR 95%CI
Total sample (N = 15715)       
None 1.49* 1.35-1.64 1.25* 1.04-1.49 1.55* 1.36-1.76
Gender 1.45* 1.31-1.60 1.31* 1.09-1.56 1.55* 1.36-1.77
SES1 1.43* 1.30-1.59 1.28* 1.07-1.53 1.52* 1.33-1.73
Occupation/Industry 1.43* 1.30-1.59 1.26* 1.05-1.51 1.50* 1.31-1.71
Omega-3 supplement 1.42* 1.29-1.58 1.26* 1.06-1.51 1.50* 1.31-1.71
Current smoking 1.43* 1.26-1.51 1.26* 1.05-1.51 1.50* 1.31-1.72
Subsample I (N = 7024)       
None 1.45* 1.24-1.69 1.41* 1.10-1.81 1.60* 1.32-1.95
Gender and SES1 1.40* 1.19-1.63 1.43* 1.11-1.84 1.56* 1.27-1.90
Fibromyalgia 1.37* 1.17-1.60 1.40* 1.08-1.80 1.51* 1.24-1.85
Other somatic diagnoses2 1.34* 1.15-1.57 1.40* 1.08-1.80 1.47* 1.20-1.80
Somatization3 1.15 0.98-1.35 1.27 0.98-1.64 1.21 0.97-1.50
Health anxiety 1.10 0.93-1.31 1.23 0.95-1.60 1.17 0.93-1.47
Adjusted for all factors above4 1.09 0.92-1.29 1.22 0.94-1.59 1.19 0.94-1.51
Female sub-sample (N = 8600)       
None 1.40* 1.23-1.58 1.16 0.88-1.53 1.66* 1.39-1.98
SES1 1.39* 1.22-1.57 1.14 0.86-1.51 1.64* 1.38-1.96
Hormonal contraceptives 1.39* 1.22-1.57 1.14 0.86-1.50 1.64* 1.38-1.96
HRT5 1.38* 1.22-1.57 1.14 0.86-1.50 1.63* 1.37-1.95
Parity 1.38* 1.22-1.56 1.14 0.86-1.50 1.62* 1.36-1.94
  1. OR, odds ratio; CI, confidence interval;
  2. *p < 0.05.
  3. 1Educational level, marital status and income;
  4. 2Self-reported somatic diagnoses and medication for somatic conditions;
  5. 3 Somatic symptoms included in symptom criteria of the ICD-10 diagnosis F45.0 Somatization disorder (skin symptoms excluded);
  6. 4Including occupation/industry, omega-3 supplement and current smoking;
  7. 5Hormonal replacement therapy (Oestrogen tablets or Plaster).